VanEck Biotech ETF
BBH
BBH
83 hedge funds and large institutions have $222M invested in VanEck Biotech ETF in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 30 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $211M → $222M (+$10.6M)
33% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 30
Holders
83
Holding in Top 10
–
Calls
$6.67M
Puts
$1.82M
Top Buyers
| 1 | +$17.1M | |
| 2 | +$3.46M | |
| 3 | +$2.45M | |
| 4 |
Morgan Stanley
New York
|
+$1.36M |
| 5 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$1.12M |
Top Sellers
| 1 | -$7.23M | |
| 2 | -$6.06M | |
| 3 | -$4.65M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.59M |
| 5 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
-$1.51M |